Table 2 The safety evaluation of the gene target site.
Total Nuclear Donor Cell Numbers | Blastocyst Numbers | Blastocyst Development Rate | ||||||
|---|---|---|---|---|---|---|---|---|
EGFP Positive (219 * 56%) | WT (219 * 44%) | Total | EGFP Positive | WT | Total | EGFP Positive | WT | Total |
~120 | ~99 | 219 | 14 | 10 | 24 | 12% | 10% | 11% |
